| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.04. | Notice of Annual General Meeting in Moberg Pharma AB (publ) | ||
| 08.04. | MOBERG PHARMA: Application submitted to include an additional terbinafine supplier | ||
| 19.02. | MOBERG PHARMA: The Nomination Committee's proposal to the Annual General Meeting 2024 | ||
| 13.02. | Moberg Pharma AB: Year-end report 2023 | LAUNCH INITIATED IN SWEDEN
THE YEAR (JAN-DEC 2023)
EBITDA SEK -25.4 million (-17.6)
Operating profit (EBIT) SEK -27.5 million (-20.2)
Profit after tax SEK -21.1 million (-15.7)
Total profit... ► Artikel lesen | |
| 07.02. | Moberg Pharma: MOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medication | STOCKHOLM, Feb. 7, 2024 /PRNewswire/ -- Moberg Pharma ABs (OMX: MOB) marker partner in Sweden - Allderma AB, a company which specialises in the sale of over-the-counter (OTC) pharmaceuticals... ► Artikel lesen |
